Beyond blood biomarkers: the role of SelectMDX in clinically significant prostate cancer identification
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beyond blood biomarkers: the role of SelectMDX in clinically significant prostate cancer identification
Authors
Keywords
-
Journal
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Volume -, Issue -, Pages -
Publisher
Informa UK Limited
Online
2023-10-28
DOI
10.1080/14737159.2023.2277366
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Protein signatures to distinguish aggressive from indolent prostate cancer
- (2022) Fernando Garcia‐Marques et al. PROSTATE
- Prostate cancer biomarkers: a practical review based on different clinical scenarios
- (2022) Ugo Giovanni Falagario et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- The promising role of new molecular biomarkers in prostate cancer: from coding and non-coding genes to artificial intelligence approaches
- (2022) Ana Paula Alarcón-Zendejas et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Combination of PI-RADS score and mRNA urine test—A novel scoring system for improved detection of prostate cancer
- (2022) Olga Katzendorn et al. PLoS One
- New strategy for the identification of prostate cancer: The combination of Proclarix and the prostate health index
- (2022) Daniela Terracciano et al. PROSTATE
- Clinical use of the mRNA urinary biomarker SelectMDx test for prostate cancer
- (2022) Wieke C. H. Visser et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Liquid Biopsy in Prostate Cancer Management—Current Challenges and Future Perspectives
- (2022) Felice Crocetto et al. Cancers
- Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer
- (2021) Irene Casanova-Salas et al. EUROPEAN UROLOGY
- Overdiagnosis in urologic cancer
- (2021) Laurence Klotz WORLD JOURNAL OF UROLOGY
- Untargeted metabolomics of prostate cancer zwitterionic and positively charged compounds in urine
- (2021) Andrea Cerrato et al. ANALYTICA CHIMICA ACTA
- Prostate cancer
- (2021) Richard J. Rebello et al. Nature Reviews Disease Primers
- Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management—Current Trends and Future Perspectives
- (2021) Octavian Sabin Tătaru et al. Diagnostics
- Radiogenomics in prostate cancer evaluation
- (2021) Ronan Thenault et al. CURRENT OPINION IN UROLOGY
- Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes
- (2021) Stefano Salciccia et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men
- (2021) Rianne J. Hendriks et al. PROSTATE CANCER AND PROSTATIC DISEASES
- SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study
- (2021) Martina Maggi et al. Cancers
- MRI-Targeted or Standard Biopsy in Prostate Cancer Screening
- (2021) Martin Eklund et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prospective study of diagnostic accuracy in the detection of high‐grade prostate cancer in biopsy‐naïve patients with clinical suspicion of prostate cancer who underwent the Select MDx test
- (2021) Guillermo Lendínez‐Cano et al. PROSTATE
- Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer
- (2021) Dominik Deniffel et al. RADIOLOGY
- Prostate Health Index and Multiparametric MRI: Partners in Crime Fighting Overdiagnosis and Overtreatment in Prostate Cancer
- (2021) Matteo Ferro et al. Cancers
- Plasmatic Exosome Number and Size Distinguish Prostate Cancer Patients From Healthy Individuals: A Prospective Clinical Study
- (2021) Mariantonia Logozzi et al. Frontiers in Oncology
- Beyond PSA: The Role of Prostate Health Index (phi)
- (2020) Matteo Ferro et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Independent Evaluation of the Respective Predictive Values for High-Grade Prostate Cancer of Clinical Information and RNA Biomarkers after Upfront MRI and Image-Guided Biopsies
- (2020) Mathieu Roumiguié et al. Cancers
- Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis
- (2020) Niranjan J. Sathianathen et al. EUROPEAN UROLOGY
- Elective procedures for prostate cancer in the time of Covid-19: a multidisciplinary team experience
- (2020) Alessandro Sciarra et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Prospective assessment of two-gene urinary test with multiparametric magnetic resonance imaging of the prostate for men undergoing primary prostate biopsy
- (2020) Gian Maria Busetto et al. WORLD JOURNAL OF UROLOGY
- Prostate Health Index and Prostate Health Index Density as Diagnostic Tools for Improved Prostate Cancer Detection
- (2020) Marija Barisiene et al. Biomed Research International
- Clinical Utility of 4Kscore, ExosomeDx and Magnetic Resonance Imaging for the Early Detection of High-Grade Prostate Cancer
- (2020) Claire M. de la Calle et al. JOURNAL OF UROLOGY
- A Urine Exosome Gene Expression Panel Distinguishes Between Indolent and Aggressive Prostate Cancers at Biopsy
- (2020) Indu Kohaar et al. JOURNAL OF UROLOGY
- Commercialized Blood-, Urinary- and Tissue-Based Biomarker Tests for Prostate Cancer Diagnosis and Prognosis
- (2020) Wieke Visser et al. Cancers
- EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
- (2020) Nicolas Mottet et al. EUROPEAN UROLOGY
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- CE–MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer
- (2019) Maria Frantzi et al. BRITISH JOURNAL OF CANCER
- Multicenter Optimization and Validation of a 2-Gene mRNA Urine Test for Detection of Clinically Significant Prostate Cancer Prior to Initial Prostate Biopsy
- (2019) Alexander Haese et al. JOURNAL OF UROLOGY
- Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients
- (2019) H.J. Boyle et al. EUROPEAN JOURNAL OF CANCER
- Randomized Study of Systematic Biopsy Versus Magnetic Resonance Imaging and Targeted and Systematic Biopsy in Men on Active Surveillance (ASIST): 2-year Postbiopsy Follow-up
- (2019) Laurence Klotz et al. EUROPEAN UROLOGY
- Multiparametric MRI Versus SelectMDx Accuracy in the Diagnosis of Clinically Significant PCa in Men Enrolled in Active Surveillance
- (2019) PIETRO PEPE et al. IN VIVO
- The MRI in Active Surveillance “MRIAS” Trial: Use of Baseline mpMRI and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate Biopsies
- (2019) Amer Amin et al. JOURNAL OF UROLOGY
- The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential
- (2018) Peter Ström et al. EUROPEAN UROLOGY
- Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging
- (2018) Henrik Grönberg et al. EUROPEAN UROLOGY
- Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer
- (2018) Daniel E. Spratt et al. JOURNAL OF CLINICAL ONCOLOGY
- Diagnostic Performance of %[-2]proPSA and Prostate Health Index for Prostate Cancer: Prospective, Multi-institutional Study
- (2018) Hongzoo Park et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Value of free/total prostate-specific antigen (f/t PSA) ratios for prostate cancer detection in patients with total serum prostate-specific antigen between 4 and 10 ng/mL
- (2018) Yan Huang et al. MEDICINE
- Genetics and biology of prostate cancer
- (2018) Guocan Wang et al. GENES & DEVELOPMENT
- Urinary biomarkers of prostate cancer
- (2018) Kazutoshi Fujita et al. INTERNATIONAL JOURNAL OF UROLOGY
- Predicting Gleason Group Progression for Men on Prostate Cancer Active Surveillance: The Role of a Negative Confirmatory MRI-US Fusion Biopsy
- (2018) Jonathan B. Bloom et al. JOURNAL OF UROLOGY
- Complications After Systematic, Random, and Image-guided Prostate Biopsy
- (2017) Marco Borghesi et al. EUROPEAN UROLOGY
- Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth
- (2017) Monique J. Roobol et al. EUROPEAN UROLOGY
- Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer
- (2017) Alexander W Wyatt et al. JNCI-Journal of the National Cancer Institute
- Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
- (2017) Hashim U Ahmed et al. LANCET
- A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection
- (2017) Rianne J. Hendriks et al. PROSTATE
- Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting
- (2017) Jay White et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer
- (2017) Alexander W Wyatt et al. JNCI-Journal of the National Cancer Institute
- Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer
- (2017) Martin G. Sanda et al. JAMA Oncology
- Screening Men at Increased Risk for Prostate Cancer Diagnosis: Model Estimates of Benefits and Harms
- (2016) Roman Gulati et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment
- (2016) Scott A. Tomlins et al. EUROPEAN UROLOGY
- Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker–Based Risk Score
- (2016) Leander Van Neste et al. EUROPEAN UROLOGY
- NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016
- (2016) Peter R. Carroll et al. Journal of the National Comprehensive Cancer Network
- Clinical Use of PCA3 and TMPRSS2:ERG Urinary Biomarkers in African-American Men Undergoing Prostate Biopsy
- (2016) Allison H. Feibus et al. JOURNAL OF UROLOGY
- Evaluation of prostate cancer antigen 3 for detecting prostate cancer: a systematic review and meta-analysis
- (2016) Yong Cui et al. Scientific Reports
- A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy
- (2016) James McKiernan et al. JAMA Oncology
- Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer
- (2015) G. H. J. M. Leyten et al. CLINICAL CANCER RESEARCH
- Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case–Control Study
- (2015) Pär Stattin et al. EUROPEAN UROLOGY
- Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study
- (2015) Henrik Grönberg et al. LANCET ONCOLOGY
- A molecular signature of PCA3 and ERG exosomal RNA from non-DRE urine is predictive of initial prostate biopsy result
- (2015) M J Donovan et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis
- (2014) K. S. Louie et al. ANNALS OF ONCOLOGY
- Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study
- (2014) Elizabeth K. Bancroft et al. EUROPEAN UROLOGY
- Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?
- (2014) John T. Wei et al. JOURNAL OF CLINICAL ONCOLOGY
- Prostate Cancer Prevention Trial Risk Calculator 2.0 for the Prediction of Low- vs High-grade Prostate Cancer
- (2014) Donna P. Ankerst et al. UROLOGY
- PCA3 Molecular Urine Test as a Predictor of Repeat Prostate Biopsy Outcome in Men with Previous Negative Biopsies: A Prospective Multicenter Clinical Study
- (2013) Marc C. Gittelman et al. JOURNAL OF UROLOGY
- Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer
- (2012) Gisele H.J.M. Leyten et al. EUROPEAN UROLOGY
- Active Surveillance Versus Surgery for Low Risk Prostate Cancer: A Clinical Decision Analysis
- (2012) David Liu et al. JOURNAL OF UROLOGY
- Diagnostic Performance of PCA3 to Detect Prostate Cancer in Men with Increased Prostate Specific Antigen: A Prospective Study of 1,962 Cases
- (2012) E. David Crawford et al. JOURNAL OF UROLOGY
- Prediction of Prostate Cancer Risk: The Role of Prostate Volume and Digital Rectal Examination in the ERSPC Risk Calculators
- (2011) Monique J. Roobol et al. EUROPEAN UROLOGY
- Gait Speed and Survival in Older Adults
- (2011) Stephanie Studenski JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Familial risk and familial survival in prostate cancer
- (2011) Kari Hemminki WORLD JOURNAL OF UROLOGY
- Critical Assessment of Preoperative Urinary Prostate Cancer Antigen 3 on the Accuracy of Prostate Cancer Staging
- (2010) Marco Auprich et al. EUROPEAN UROLOGY
- Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer
- (2009) Daphne Hessels et al. PROSTATE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now